Dexcel Pharma USA Acquires US Rights to Zubsolv®
PR Newswire —
Parsippany, N.J., Jan. 7, 2026 /PRNewswire/ -- Dexcel Pharma USA is excited to announce the successful closing of an Asset Purchase Agreement with Orexo AB to acquire the U.S. rights to Zubsolv® (buprenorphine and naloxone) sublingual tablets and the associated commercial infrastructure....